SCHEMBL6062843

SCHEMBL6062843

CN(C)[C@@H](CS(=O)(=O)Cc1ccccc1)C(=O)NCCCCC(=O)c1nc2ccccc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPK1 P28482 1/20 0.43
HTR1A P08908 8/20 0.43
DRD2 P14416 8/20 0.43
HTR7 P34969 8/20 0.43
HTR2A P28223 7/20 0.43
SLC6A4 P31645 5/20 0.43
HTR2C P28335 2/20 0.43
HRH1 P35367 2/20 0.43
SLC6A2 P23975 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
MCL1 Q07820 1/20 0.42
ALOX5 P09917 2/20 0.40
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6063802 0.90 HPGD (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6062888 0.85 MAPK1 (0.43) NPC1RAB9AHPGDMAPK1L3MBTL1
SCHEMBL6633338 0.85 MAPK1 (0.43) NPC1RAB9AHPGDMAPK1L3MBTL1
SCHEMBL6061815 0.85 NPC1 (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6629355 0.84 NPC1 (0.49) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6629063 0.84 NPC1 (0.49) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6631047 0.81 DAGLA (0.52) ALDH1A1
SCHEMBL6631134 0.79 DRD2 (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6689469 0.78 MAPK1 (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPK1
SCHEMBL6062841 0.78 MAPK1 (0.44) NPC1RAB9AHPGDSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed